+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

Homoeopathy medicines add-ons allowed in COVID-19 treatment, says Youth Affairs and Sports Minister

Feb 12, 2021, 18:20 IST
IANS
New Delhi, The Supreme Court has upheld the Ayush Ministry's advisory to permit use of homoeopathy medicines as add-ons to standard care in Covid-19 treatment, Parliament was told on Friday.
Advertisement

In a written reply in the Lok Sabha, Youth Affairs and Sports Minister Kiren Rijiju, who holds additional charge of the Ayush Ministry, said that while homoeopathy treatment is not to be given in standalone mode for Covid-19 treatment, Ayush interventions, including homoeopathy, as add-on to standard care are allowed.

He also said that the Ayush Ministry has taken many steps with the help of other systems of medicine, including homeopathy, for Covid-19-related treatment.

The Minister also cited the Ministry's letter dated March 6, 2020 to all Chief Secretaries of states and Union Territories, conveying specific suggestions on augmentation of general immunity of people and about possible Ayush interventions.

He also mentioned the self-care guidelines issued by the Ministry on March 31, 2020 for preventive health measures and enhancing immunity with special reference to respiratory health.

Advertisement

Further, the Ayush Ministry, through various research organisations and National Institutes under it, has conducted 105 interdisciplinary clinical studies (including 20 studies of homoeopathy) at 136 centres in the country.

Clinical research studies are conducted on Ayush interventions as prophylactic interventions in high risk population targeting approximately five lakhs population and as an add-on to standard care to Covid-19 management.



SEE ALSO:
Here’s why Grofers may allow an American “blank cheque” firm to buy it out instead of fighting Ambani and BigBasket for IPO
SpiceJet and IndiGo stocks take off as a 2-hour flight could now cost up to ₹13,000
Centre earned ₹100 crores by sharing vehicle registration data with companies such as BMW, Axis Bank, Bajaj Allianz, L&T and others
You are subscribed to notifications!
Looks like you've blocked notifications!
Next Article